New Venturetec announced earnings results for the year ended September 30, 2014. The company closed the fiscal year 2013/14, ended September 30, 2014, with a loss of USD 20,639,722, compared to a gain of USD 16,857,382 in the fiscal year 2012/13. The main reason for the loss was the decrease of the quoted share price of Osiris Therapeutics and a write down on the investment in mPortal.

The net asset value per share decreased from USD 14.01 to USD 9.93 which equals -29.1% during the reporting period; in CHF respectively from CHF 12.67 to CHF 9.48 or -25.2%. The main reason for the loss was the decrease of the quoted share price of Osiris Therapeutics by 24.3% from USD 16.64 to USD 12.59 and a write down on the investment in the private company mPortal. The details on the valuation of the portfolio companies are described in the annual report.